跳至主要内容
临床试验/NCT04883190
NCT04883190已完成不适用

Physical and Mental Fatigue a Long COVID-19 Symptom - Substudy of FSC19-KN Trial

Hegau-Bodensee-Klinikum Singen1 个研究点 分布在 1 个国家目标入组 353 人开始时间: 2021年5月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
353
试验地点
1
主要终点
Presence of fatigue

研究概览

简要总结

Prospective, controlled follow-up observation of SARS-CoV-2 positive patients with regard to the aspect of fatigue (cognitive / motor) and psychological disorders in the areas of anxiety, depression and somatization.

详细描述

After informed consent is given, questionnaires will be obtained 6 months and 12 months after infection. For analyzing cognitive and motor fatigue, classified in mildly, moderately or severely fatigue the questionnaire will be calculated by The Fatigue Scale for Motor and Cognitive Functions (FSMC).

And the occurrence of Major Depressive Disorder, other depressive Syndrome or Panic syndrome measured by Brief Patient Health Questionnaire.

The FSC19-KN trial already included patients with positive test for SARS-CoV-2 by PCR and volunteers with negative SARS-CoV-2 antibody testing. Verification of exclusion criteria had been completed in the main trial FSC19-KN. After the informed consent to participation in the sub-study is given all inclusion modalities are fulfilled.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient must meet ALL of the following criteria.
  • Participation in the FSC19-KN study
  • Consent to participate in the survey

排除标准

  • Failure to give consent to the survey

结局指标

主要结局

Presence of fatigue

时间窗: 12 month after infection

Evaluate cognitive and motor fatigue classified in mildly, moderately or severely fatigue

次要结局

  • Occurrence of Major Depressive Disorder, other depressive Syndrome or Panic syndrome.(12 month after infection)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验